| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Coronary Artery Disease | 8 | 2020 | 2570 | 1.29 | Why? |
| Antibodies, Antiphospholipid | 2 | 2020 | 519 | 1.18 | Why? |
| Disseminated Intravascular Coagulation | 2 | 2020 | 994 | 0.80 | Why? |
| Hydrazines | 1 | 2020 | 68 | 0.80 | Why? |
| Benzoates | 1 | 2020 | 102 | 0.79 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 71 | 0.76 | Why? |
| Coronary Vessels | 5 | 2018 | 914 | 0.74 | Why? |
| Chemokine CCL2 | 1 | 2020 | 389 | 0.72 | Why? |
| Apolipoproteins E | 2 | 2018 | 170 | 0.72 | Why? |
| Histone Deacetylase Inhibitors | 1 | 2018 | 79 | 0.71 | Why? |
| Chemokine CCL17 | 1 | 2017 | 30 | 0.70 | Why? |
| Mendelian Randomization Analysis | 1 | 2020 | 317 | 0.69 | Why? |
| Takayasu Arteritis | 1 | 2017 | 83 | 0.65 | Why? |
| Pulse Wave Analysis | 1 | 2018 | 221 | 0.65 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2017 | 202 | 0.64 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.63 | Why? |
| RNA, Long Noncoding | 2 | 2018 | 408 | 0.62 | Why? |
| Telomere | 1 | 2017 | 146 | 0.60 | Why? |
| Aorta | 1 | 2018 | 355 | 0.60 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.55 | Why? |
| Plaque, Atherosclerotic | 1 | 2018 | 423 | 0.53 | Why? |
| Heart Atria | 1 | 2016 | 267 | 0.53 | Why? |
| Rare Diseases | 1 | 2018 | 373 | 0.52 | Why? |
| Patient Admission | 2 | 2020 | 5250 | 0.51 | Why? |
| Cardiology Service, Hospital | 1 | 2020 | 602 | 0.50 | Why? |
| Thyroxine | 1 | 2015 | 250 | 0.49 | Why? |
| Uric Acid | 1 | 2015 | 285 | 0.45 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.44 | Why? |
| Myocytes, Cardiac | 1 | 2017 | 804 | 0.43 | Why? |
| Critical Illness | 7 | 2021 | 17281 | 0.43 | Why? |
| Pulmonary Artery | 1 | 2017 | 803 | 0.42 | Why? |
| Thyroid Gland | 1 | 2015 | 516 | 0.40 | Why? |
| Hospitals, Teaching | 1 | 2018 | 1609 | 0.39 | Why? |
| Pyrazoles | 1 | 2020 | 1791 | 0.39 | Why? |
| Educational Measurement | 1 | 2017 | 930 | 0.39 | Why? |
| Myocardial Infarction | 3 | 2020 | 3361 | 0.38 | Why? |
| Plasma | 1 | 2019 | 1809 | 0.37 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.36 | Why? |
| Hospital Charges | 2 | 2018 | 56 | 0.35 | Why? |
| MicroRNAs | 2 | 2018 | 1787 | 0.35 | Why? |
| Cerebral Small Vessel Diseases | 2 | 2018 | 89 | 0.34 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.33 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.33 | Why? |
| Genetic Predisposition to Disease | 3 | 2020 | 4027 | 0.32 | Why? |
| Image Enhancement | 2 | 2018 | 177 | 0.32 | Why? |
| Coronary Angiography | 5 | 2018 | 2275 | 0.32 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.32 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2018 | 1380 | 0.32 | Why? |
| Viral Nonstructural Proteins | 2 | 2021 | 4810 | 0.32 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.31 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.31 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.30 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.30 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.29 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.29 | Why? |
| Cardiovascular Diseases | 2 | 2020 | 11497 | 0.29 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.28 | Why? |
| Lymphocytes | 1 | 2018 | 3056 | 0.28 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.28 | Why? |
| Pressure Ulcer | 2 | 2020 | 398 | 0.28 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.27 | Why? |
| Education, Medical, Graduate | 1 | 2018 | 2082 | 0.26 | Why? |
| Magnetic Resonance Imaging, Cine | 2 | 2018 | 669 | 0.25 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.24 | Why? |
| Fibrillin-1 | 2 | 2018 | 6 | 0.23 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.23 | Why? |
| Myocarditis | 1 | 2017 | 2731 | 0.22 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.22 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.22 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.22 | Why? |
| Exudates and Transudates | 1 | 2020 | 92 | 0.22 | Why? |
| Suramin | 1 | 2021 | 76 | 0.21 | Why? |
| White Matter | 3 | 2019 | 369 | 0.21 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.21 | Why? |
| Percutaneous Coronary Intervention | 4 | 2019 | 3646 | 0.21 | Why? |
| Exome | 2 | 2019 | 207 | 0.21 | Why? |
| Cerebral Hemorrhage | 2 | 2019 | 820 | 0.21 | Why? |
| Humans | 57 | 2021 | 930598 | 0.21 | Why? |
| Atherosclerosis | 2 | 2019 | 768 | 0.20 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2020 | 93 | 0.20 | Why? |
| Female | 34 | 2021 | 380317 | 0.20 | Why? |
| Male | 34 | 2021 | 367725 | 0.20 | Why? |
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2019 | 10 | 0.20 | Why? |
| Heart Failure | 2 | 2020 | 6638 | 0.20 | Why? |
| Receptors, LDL | 1 | 2018 | 42 | 0.19 | Why? |
| Heart Diseases | 1 | 2016 | 3503 | 0.19 | Why? |
| Aged | 24 | 2021 | 215776 | 0.19 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.19 | Why? |
| Protein Array Analysis | 1 | 2021 | 387 | 0.19 | Why? |
| Germ-Line Mutation | 1 | 2019 | 86 | 0.19 | Why? |
| Computer Simulation | 3 | 2020 | 4982 | 0.19 | Why? |
| Image Processing, Computer-Assisted | 2 | 2018 | 1383 | 0.19 | Why? |
| Familial Primary Pulmonary Hypertension | 1 | 2019 | 68 | 0.19 | Why? |
| Basilar Artery | 1 | 2018 | 31 | 0.19 | Why? |
| Angina, Unstable | 1 | 2019 | 110 | 0.19 | Why? |
| Antibodies, Anticardiolipin | 1 | 2020 | 208 | 0.18 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.18 | Why? |
| Hemofiltration | 1 | 2020 | 155 | 0.18 | Why? |
| Thrombosis | 2 | 2020 | 7504 | 0.18 | Why? |
| Middle Aged | 26 | 2021 | 270681 | 0.18 | Why? |
| Vertebrobasilar Insufficiency | 1 | 2018 | 40 | 0.18 | Why? |
| Radiographic Image Enhancement | 1 | 2018 | 89 | 0.18 | Why? |
| China | 13 | 2021 | 50654 | 0.18 | Why? |
| Intracranial Arteriosclerosis | 1 | 2018 | 46 | 0.18 | Why? |
| Students, Medical | 1 | 2017 | 4032 | 0.17 | Why? |
| Marfan Syndrome | 1 | 2017 | 27 | 0.17 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.17 | Why? |
| Transcription Factor AP-1 | 1 | 2017 | 75 | 0.17 | Why? |
| Telomere Homeostasis | 1 | 2017 | 52 | 0.17 | Why? |
| Protein Stability | 1 | 2020 | 756 | 0.17 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 502 | 0.16 | Why? |
| JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 59 | 0.16 | Why? |
| Hyperlipoproteinemia Type II | 1 | 2018 | 123 | 0.16 | Why? |
| Hippocampus | 1 | 2019 | 237 | 0.16 | Why? |
| Janus Kinases | 1 | 2020 | 414 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Coronary Circulation | 1 | 2018 | 188 | 0.16 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.16 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.15 | Why? |
| Models, Cardiovascular | 1 | 2017 | 153 | 0.15 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.15 | Why? |
| Movement Disorders | 1 | 2018 | 186 | 0.15 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.15 | Why? |
| Gene Deletion | 1 | 2017 | 430 | 0.15 | Why? |
| Movement | 1 | 2017 | 232 | 0.15 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.15 | Why? |
| Tracheotomy | 1 | 2020 | 427 | 0.14 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 230 | 0.14 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.14 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.14 | Why? |
| Flavanones | 1 | 2016 | 141 | 0.14 | Why? |
| Catheterization | 1 | 2017 | 264 | 0.14 | Why? |
| Phenotype | 4 | 2018 | 4037 | 0.14 | Why? |
| Genetic Variation | 2 | 2020 | 3919 | 0.14 | Why? |
| Hyperthyroidism | 1 | 2015 | 63 | 0.14 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.14 | Why? |
| Myocardial Revascularization | 1 | 2016 | 267 | 0.14 | Why? |
| Microvessels | 1 | 2019 | 490 | 0.14 | Why? |
| Reactive Oxygen Species | 2 | 2017 | 1136 | 0.14 | Why? |
| Echocardiography | 3 | 2017 | 3661 | 0.13 | Why? |
| Mammography | 1 | 2018 | 410 | 0.13 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.13 | Why? |
| Interleukin-6 | 3 | 2020 | 7522 | 0.13 | Why? |
| MAP Kinase Signaling System | 1 | 2016 | 360 | 0.13 | Why? |
| Aortic Aneurysm, Abdominal | 1 | 2016 | 155 | 0.13 | Why? |
| Structure-Activity Relationship | 1 | 2020 | 2219 | 0.13 | Why? |
| Algorithms | 3 | 2020 | 7346 | 0.13 | Why? |
| Aneurysm, Dissecting | 1 | 2018 | 303 | 0.13 | Why? |
| Enzyme Inhibitors | 2 | 2021 | 1881 | 0.13 | Why? |
| Vasculitis | 1 | 2020 | 691 | 0.12 | Why? |
| Myxoma | 1 | 2012 | 16 | 0.12 | Why? |
| Plasma Exchange | 1 | 2020 | 763 | 0.12 | Why? |
| Intracranial Aneurysm | 1 | 2018 | 504 | 0.12 | Why? |
| Retrospective Studies | 10 | 2020 | 105322 | 0.12 | Why? |
| Hypothyroidism | 1 | 2015 | 239 | 0.12 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.12 | Why? |
| Linear Models | 2 | 2018 | 1914 | 0.12 | Why? |
| Independent Living | 1 | 2019 | 842 | 0.12 | Why? |
| Respiration | 1 | 2017 | 729 | 0.12 | Why? |
| Protein Binding | 2 | 2020 | 11430 | 0.12 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.12 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.11 | Why? |
| Decision Support Techniques | 1 | 2019 | 903 | 0.11 | Why? |
| Heart Neoplasms | 1 | 2012 | 77 | 0.11 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.11 | Why? |
| Coronary Artery Bypass | 1 | 2017 | 629 | 0.11 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.11 | Why? |
| Drug-Eluting Stents | 1 | 2017 | 562 | 0.11 | Why? |
| Noncommunicable Diseases | 1 | 2020 | 934 | 0.11 | Why? |
| Brain | 2 | 2018 | 5133 | 0.11 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 869 | 0.11 | Why? |
| Airway Management | 1 | 2020 | 1298 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.10 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.10 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.10 | Why? |
| Magnetic Resonance Imaging | 4 | 2019 | 6551 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.10 | Why? |
| Adult | 11 | 2020 | 244371 | 0.10 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.10 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.10 | Why? |
| Myosin Heavy Chains | 2 | 2018 | 26 | 0.10 | Why? |
| Kidney | 2 | 2021 | 3648 | 0.10 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.10 | Why? |
| Models, Molecular | 2 | 2020 | 7616 | 0.09 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2018 | 997 | 0.09 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.09 | Why? |
| Binding Sites | 2 | 2021 | 6201 | 0.09 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.09 | Why? |
| Dilatation, Pathologic | 2 | 2018 | 78 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.09 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2019 | 1671 | 0.09 | Why? |
| Mice | 2 | 2018 | 21357 | 0.09 | Why? |
| Thrombolytic Therapy | 1 | 2020 | 2218 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.09 | Why? |
| Drug Design | 1 | 2020 | 2627 | 0.09 | Why? |
| Atrophy | 2 | 2018 | 192 | 0.09 | Why? |
| Organ Size | 2 | 2019 | 384 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Heart | 1 | 2016 | 1791 | 0.08 | Why? |
| Hemorrhage | 1 | 2019 | 3013 | 0.08 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.08 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.08 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.08 | Why? |
| Tomography, X-Ray Computed | 3 | 2017 | 25144 | 0.08 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.08 | Why? |
| Adolescent | 5 | 2020 | 86841 | 0.07 | Why? |
| Acute Coronary Syndrome | 1 | 2019 | 2107 | 0.07 | Why? |
| Cardiology | 1 | 2020 | 2873 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Stroke | 2 | 2018 | 8839 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Tomography, Spiral Computed | 1 | 2004 | 109 | 0.07 | Why? |
| Catalytic Domain | 2 | 2021 | 1757 | 0.07 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.07 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.07 | Why? |
| Pandemics | 11 | 2020 | 389249 | 0.07 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.06 | Why? |
| Cryoelectron Microscopy | 2 | 2021 | 2372 | 0.06 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.06 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Chronic Disease | 1 | 2016 | 5139 | 0.06 | Why? |
| Animals | 4 | 2021 | 78931 | 0.06 | Why? |
| Population Surveillance | 1 | 2019 | 4967 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Registries | 2 | 2019 | 12327 | 0.05 | Why? |
| Coronary Stenosis | 1 | 2004 | 273 | 0.05 | Why? |
| Lung | 2 | 2021 | 31049 | 0.05 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2016 | 3051 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.05 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.05 | Why? |
| Protein Conformation | 2 | 2021 | 4386 | 0.05 | Why? |
| Adenine Nucleotide Translocator 1 | 1 | 2018 | 1 | 0.05 | Why? |
| Molecular Motor Proteins | 1 | 2018 | 4 | 0.05 | Why? |
| Connectin | 1 | 2018 | 6 | 0.05 | Why? |
| Cardiac Myosins | 1 | 2018 | 15 | 0.05 | Why? |
| Multiprotein Complexes | 1 | 2020 | 182 | 0.05 | Why? |
| Collagen Type III | 1 | 2018 | 12 | 0.05 | Why? |
| Normal Distribution | 1 | 2018 | 64 | 0.05 | Why? |
| Cardiomyopathy, Restrictive | 1 | 2018 | 30 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Leukoaraiosis | 1 | 2018 | 18 | 0.05 | Why? |
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2018 | 56 | 0.05 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.05 | Why? |
| Coronary Disease | 1 | 2004 | 645 | 0.04 | Why? |
| Conscious Sedation | 1 | 2020 | 222 | 0.04 | Why? |
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 96 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.04 | Why? |
| DNA Copy Number Variations | 1 | 2017 | 84 | 0.04 | Why? |
| Fibrosis | 1 | 2021 | 800 | 0.04 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Exons | 1 | 2017 | 158 | 0.04 | Why? |
| Elastin | 1 | 2016 | 16 | 0.04 | Why? |
| Gray Matter | 1 | 2018 | 150 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2018 | 193 | 0.04 | Why? |
| Spleen | 1 | 2021 | 877 | 0.04 | Why? |
| Phantoms, Imaging | 1 | 2017 | 146 | 0.04 | Why? |
| Internship and Residency | 1 | 2018 | 4987 | 0.04 | Why? |
| Magnetic Resonance Angiography | 1 | 2018 | 282 | 0.04 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2016 | 85 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 193 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2018 | 689 | 0.04 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.04 | Why? |
| Cardiomyopathy, Dilated | 1 | 2018 | 251 | 0.04 | Why? |
| Receptor, Angiotensin, Type 1 | 1 | 2016 | 160 | 0.04 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.04 | Why? |
| Everolimus | 1 | 2017 | 215 | 0.04 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2016 | 211 | 0.04 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Cholesterol, HDL | 1 | 2018 | 439 | 0.03 | Why? |
| Cholesterol, LDL | 1 | 2018 | 499 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Blotting, Western | 1 | 2016 | 863 | 0.03 | Why? |
| Protective Agents | 1 | 2016 | 250 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.03 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2018 | 436 | 0.03 | Why? |
| Anemia | 1 | 2020 | 789 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Mice, Knockout | 1 | 2016 | 1815 | 0.03 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.03 | Why? |
| Angiotensin II | 1 | 2016 | 601 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.03 | Why? |
| User-Computer Interface | 1 | 2017 | 1068 | 0.03 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.03 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.02 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.02 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Virus Replication | 2 | 2021 | 14331 | 0.02 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2016 | 2275 | 0.02 | Why? |
| Endothelial Cells | 1 | 2019 | 2048 | 0.02 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.02 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Antioxidants | 1 | 2016 | 1593 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.02 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2017 | 5486 | 0.01 | Why? |
| Imaging, Three-Dimensional | 1 | 2004 | 680 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Heart Rate | 1 | 2004 | 1527 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Child, Preschool | 1 | 2012 | 36283 | 0.01 | Why? |
| Child | 1 | 2012 | 70012 | 0.00 | Why? |